Penfluridol, a diphenylbutylpiperidine antipsychotic drug, has a longer elimination half-life than thioridazine, trifluoperazine, and pimozide when used to treat schizophrenia via targeting DRD2 [20, 21]. This evidence concerns the gene DRD2 and schizophrenia.